Lunsumio
NDC 50242-159, Mosunetuzumab, concentrate, from Genentech, Inc..
- Product NDC
- 50242-159
- Status
- Listed
- Labeler
- Genentech, Inc.
- Dosage form
- CONCENTRATE
- Route
- INTRAVENOUS
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- BLA
- Application
- BLA761263
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/50242-159 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- MOSUNETUZUMAB1 mg/mL
| Package NDC | NDC-11 | Package |
|---|---|---|
| 50242-159-01 | 50242015901 | 1 VIAL in 1 CARTON (50242-159-01) / 1 mL in 1 VIAL |
Linked data
RxNorm, label and prices
Related lookups
FDA label sections
GET /v1/drugs/labels/2ef0cf38-101c-4681-98fe-c05dc9ead443Medicare Part B payment limits (ASP)
GET /v1/drugs/asp?ndc=50242-159
Use it
Look up 50242-159 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/50242-159 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 50242-159. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.